Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-14 11:32 am Purchase | 2022-12-31 | 13G | European Biotech Acquisition Corp. EBAC | GLAZER CAPITAL LLC | 1,254,733 9.500% | 1,254,733![]() (New Position) | Filing History |
2023-02-13 4:04 pm Purchase | 2022-12-31 | 13G | European Biotech Acquisition Corp. EBAC | Periscope Capital Inc. | 776,797 5.880% | 776,797![]() (New Position) | Filing History |
2023-02-06 4:43 pm Sale | 2022-12-31 | 13G | European Biotech Acquisition Corp. EBAC | INTEGRATED CORE STRATEGIES (US) LLC | 793,018 6.000% | -19,042![]() (-2.34%) | Filing History |
2022-02-14 06:19 am Purchase | 2021-12-31 | 13G | European Biotech Acquisition Corp. EBAC | CITADEL ADVISORS LLC | 625,909 4.700% | 625,909![]() (New Position) | Filing History |
2022-02-08 4:10 pm Purchase | 2021-12-31 | 13G | European Biotech Acquisition Corp. EBACU | LSP Sponsor EBAC B.V. | 3,593,792 21.920% | 3,593,792![]() (New Position) | Filing History |
2022-01-27 4:35 pm Purchase | 2021-12-31 | 13G | European Biotech Acquisition Corp. EBAC | INTEGRATED CORE STRATEGIES (US) LLC | 812,060 6.100% | 812,060![]() (New Position) | Filing History |
2021-04-02 4:01 pm Purchase | 2021-03-23 | 13G | European Biotech Acquisition Corp. EBACU | CITADEL ADVISORS LLC | 625,093 5.000% | 625,093![]() (New Position) | Filing History |
2021-03-24 4:13 pm Purchase | 2021-03-16 | 13G | European Biotech Acquisition Corp. EBACU | INTEGRATED CORE STRATEGIES (US) LLC | 870,000 7.000% | 870,000![]() (New Position) | Filing History |